HOME >> BIOLOGY >> NEWS
Retroviral protein triggers proliferation of immune cells

Columbus, Ohio Scientists here have found that a protein in the retrovirus known as human T-cell lymphotropic virus type 1 (HTLV-1) can cause immune cells to divide and proliferate, helping the virus spread through the body.

The protein, known as p12, was formerly thought to be unimportant during infection, causing scientists to regard it as a nonessential "accessory gene."

This new study, however, shows that the protein forces infected cells to produce interleukin 2 (IL-2), a substance that stimulates the growth and proliferation of immune cells known as T lymphocytes, or T cells, which are the virus's chief target. The study was published in the Oct. 15 issue of the Journal of Virology.

"Our findings help explain why lymphocytes divide and proliferate in people following HTLV-1 infection," says lead investigator Michael D. Lairmore, professor and chair of veterinary biosciences, professor of molecular virology and associate director for basic sciences at the Ohio State University Comprehensive Cancer Center. "The findings also support the view that this virus replicates mainly by causing infected cells to divide and proliferate rather than by generating more virus particles."

The study provides insight into the biology of HTLV-1 and the changes lymphocytes undergo as they become cancerous. The findings also may lead to safer, more effective drugs to treat the leukemias, lymphoma, and autoimmune-like diseases caused by the virus.

HTLV-1 infects 15 to 25 million people worldwide, particularly in Japan and in the Caribbean region. It specifically attacks immune cells known as CD4 lymphocytes, where it inserts its genome, or genetic material, permanently into a chromosome. In some people the virus causes adult T-cell leukemia/lymphoma, a cancer that responds poorly to treatment and that can cause death within six months of diagnosis. In others, it causes crippling and painful autoimmune-like disorders.

Lairmore and a
'"/>

Contact: Darrell E. Ward
Ward-15@medctr.osu.edu
614-293-3737
Ohio State University
22-Oct-2003


Page: 1 2

Related biology news :

1. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
2. New molecular link key to cellular proteins involved in cancer progression, other diseases
3. Researchers identify protein promoting vascular tumor growth
4. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
5. Experimental drug shown to block mutant protein causing blood disease
6. Loss of the neuronal adhesion protein d-catenin leads to severe cognitive dysfunction
7. Images of tail of protein needed for cell multiplication suggest anticancer drug targets
8. New dye directly reveals activated proteins in living cells
9. Disruption of protein-folding causes neurodegeneration, mental retardation
10. A new protein is discovered to play a key role in cancer progression
11. Optimizing proteins death domain halts leukemia in laboratory study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/29/2020)... ... January 29, 2020 , ... Jason ... and Data Sciences practice, providing consulting services for strategy, research and development and ... Mike Townley, co-founder and Managing Partner of CREO, an innovative management consulting and ...
(Date:1/28/2020)... (PRWEB) , ... January 28, 2020 , ... ... life sciences companies and government agencies, announced that the firm has established a ... country. Tunnell’s Cambridge office will be in the Cambridge Innovation Center (CIC), at ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cytonus Therapeutics Inc. today ... tech entrepreneur, and former senior management consultant at McKinsey & Company who holds ... alternative investment firm. , “Chris Thorne has exceptional business acumen with a ...
Breaking Biology News(10 mins):
(Date:2/3/2020)... ... February 03, 2020 , ... ... MA, announce that OmniType, the 11-locus, single tube multiplex successor to Holotype HLA ... best-in-class product featuring locus-multiplexing and short library preparation, for HLA genotyping from sample ...
(Date:1/28/2020)... (PRWEB) , ... January 28, ... ... of enterprise software solutions for biopharmaceutical R&D, today announced the release of ... reinforces Genedata’s focus on supporting the implementation of Multi-Attribute Methods (MAM) for ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cerebyte, the leader in “instant ... today announced the availability of neuroscience of transformational leadership workshops. These highly interactive, ... of leadership and change research to become great transformational leaders. The workshops ...
(Date:1/24/2020)... ... January 24, 2020 , ... The plastic and reconstructive surgeons at ... New Jersey epitomize the notion that plastic surgery is much more than just cosmetic ... media. , Over the last 20 years NJ Top Docs, Dr. Andrew Elkwood, Dr. ...
Breaking Biology Technology:
Cached News: